Sichuan Sanchine-Sunnyhope Pharmaceutical

Sichuan Sanchine-Shenghe Pharmaceutical, also known as Sichuan Sanchine-Sunnyhope Pharmaceutical, is a prominent Chinese pharmaceutical manufacturer based in Chengdu and a subsidiary of the Harbin Pharmaceutical Group (Hayao). The company specializes in the research, development, and large-scale production of chemical drugs and Traditional Chinese Medicine (TCM), with a particular emphasis on injectable formulations under the "Shenghe" brand. Its product portfolio covers critical therapeutic areas including cardiovascular and cerebrovascular diseases, anti-infectives, and gastroenterology. Operating with extensive GMP-certified facilities, the company serves as a major regional hub for its parent group's operations in Southwest China. The company maintains a strong market presence across China's hospital and retail sectors through its diverse range of approved medications.